Download Files:
Products Details
Product Description
– Avotaciclib (BEY1107) is a potent and orally active inhibitor of cyclin dependent kinase 1 (CDK1). Avotaciclib can be used for the research of locally advanced or metastatic pancreatic cancer[1].
Web ID
– HY-137432
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C13H11N7O
References
– [1]Seufferlein T, et, al. Phase I Trials in Pancreatic Cancer. Translational Pancreatic Cancer Research pp 219-232.
CAS Number
– 1983983-41-0
Molecular Weight
– 281.27
SMILES
– OC1=CC=C(C2=NC(N)=NC=C2)N=C1C3=NC(N)=NC=C3
Clinical Information
– Phase 2
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– CDK
Isoform
– CDK1
Pathway
– Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
